Skip to main content
. 2017 May 10;129(15):540–544. doi: 10.1007/s00508-017-1207-x

Table 2.

Distribution of BRAF and NRAS mutations across T‑stage and N‑stage

BRAF NRAS
BRAF mutations
(n = 23)
No BRAF mutation
(n = 30)
NRAS mutation
(n = 2)
No NRAS mutation
(n = 51)
T1a
(n = 18)
11 7 18
T1b
(n = 13)
6 7 1 12
T2
(n = 9)
2 7 1 8
T3
(n = 13)
4 9 13
N0
(n = 39)
16 23 2 37
N1a
(n = 8)
5 3 8
N1b
(n = 6)
2 4 6

n number of cases, BRAF B-type Raf kinase, NRAS Neuroblastoma RAS Viral Oncogene Homolog